AEterna Zentaris Inc (NASDAQ:AEZS)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - AEZS
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - AEZS
- Market Cap$43.680m
- SymbolNASDAQ:AEZS
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINCA0079754028
Company Profile
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company is actively pursuing opportunities to commercialize macimorelin in the EU & the rest of the world.AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology, endocrinology and women's health.
Latest AEZS news
Currently there for this company. Visit our news hub for other news .